The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Buianova S.N.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Babunashvili E.L.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia

Zubova E.S.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia

Iudina N.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Rizhinashvili I.D.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

The efficiency and safety of using the gonadotropin-releasing hormone agonist Buserelin-long FS in late reproductive-aged patients with endometriosis: A clinical trial

Authors:

Buianova S.N., Babunashvili E.L., Zubova E.S., Iudina N.V., Rizhinashvili I.D.

More about the authors

Views: 26883

Downloaded: 254


To cite this article:

Buianova SN, Babunashvili EL, Zubova ES, Iudina NV, Rizhinashvili ID. The efficiency and safety of using the gonadotropin-releasing hormone agonist Buserelin-long FS in late reproductive-aged patients with endometriosis: A clinical trial. Russian Bulletin of Obstetrician-Gynecologist. 2016;16(5):87‑94. (In Russ.)
https://doi.org/10.17116/rosakush201616587-94

Recommended articles:
Quality of life and psychosomatic status of women of reproductive age with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):83-89
The role of ferroptosis in reproduction. A modern view of the problem. Russian Journal of Human Reproduction. 2024;(5):35-45

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.